Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Aberrant Crypt Foci
Effects of di(2-ethylhexyl)phthalate exposure on 1,2-dimethyhydrazine-induced colon tumor promotion in rats.
Aberrant Crypt Foci
Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats.
Abortion, Habitual
Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage.
Abortion, Habitual
Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.
Abortion, Habitual
Luteal phase defect is associated with impaired VEGF mRNA expression in the secretory phase endometrium.
Abortion, Habitual
miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9.
Abortion, Habitual
Recurrent miscarriage is associated with increased ghrelin mRNA expression in the endometrium- a case-control study.
Abortion, Habitual
Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss.
Abortion, Habitual
Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages.
Abortion, Incomplete
Factors related to completeness of medical abortion with mifepristone and misoprostol.
Abortion, Missed
Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) and Serum Placental Growth Factor (PlGF) as Biomarkers for Ectopic Pregnancy and Missed Abortion.
Abortion, Spontaneous
An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion.
Abortion, Spontaneous
Assessment of the transcription levels for the complement activation control system in eutopic endometrium in women with two or more consecutive miscarriages of unknown etiology.
Abortion, Spontaneous
Association of angiogenic cytokines (VEGF-A and VEGF-C) and clinical characteristic in women with unexplained recurrent miscarriage.
Abortion, Spontaneous
Association of serum levels of vascular endothelial growth factor and early ectopic pregnancy.
Abortion, Spontaneous
Association of Vascular Endothelial Growth Factor Gene Polymorphisms with Recurrent Spontaneous Abortion in Chinese Han Women.
Abortion, Spontaneous
Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis.
Abortion, Spontaneous
Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion.
Abortion, Spontaneous
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
Abortion, Spontaneous
Dynamics and reproductive effects of complement factors in the spontaneous abortion model of CBA/J×DBA/2 mice.
Abortion, Spontaneous
Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage.
Abortion, Spontaneous
Elevation of Adipsin, a Complement Activating Factor, in the Mouse Placenta During Spontaneous Abortion.
Abortion, Spontaneous
Expression of ATF4 and VEGF in chorionic villus tissue in early spontaneous abortion.
Abortion, Spontaneous
Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.
Abortion, Spontaneous
Genetic variation in vascular endothelial growth factor gene and its association with recurrent spontaneous abortion.
Abortion, Spontaneous
Identification of specific vascular endothelial growth factor susceptible and protective haplotypes associated with recurrent spontaneous miscarriages.
Abortion, Spontaneous
Involvement of heparanase in vaginal and cesarean section deliveries.
Abortion, Spontaneous
Low VEGF expression in conceptus material and maternal serum AFP and ?-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages.
Abortion, Spontaneous
Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment.
Abortion, Spontaneous
MicroRNA-16 inhibits feto-maternal angiogenesis and causes recurrent spontaneous abortion by targeting vascular endothelial growth factor.
Abortion, Spontaneous
Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage.
Abortion, Spontaneous
Prenatal depression and stress - risk factors for placental pathology and spontaneous abortion.
Abortion, Spontaneous
Production of vascular endothelial growth factor and endothelin in the placenta and umbilical cord during normal and complicated pregnancy.
Abortion, Spontaneous
Regulation of Complement Activity via the Alternative Pathway in Placentas of Mouse Spontaneous Abortions.
Abortion, Spontaneous
Regulation of natural-killer cell cytotoxicity and enhancement of complement factors in the spontaneously aborted mouse placenta.
Abortion, Spontaneous
Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage.
Abortion, Spontaneous
Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?
Abortion, Spontaneous
The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion.
Abortion, Spontaneous
The role of VEGF and its receptors in the etiology of early pregnancy loss.
Abortion, Spontaneous
The value of vascular endothelial growth factor, pregnancy-associated plasma protein-A, and progesterone for early differentiation of ectopic pregnancies, normal intrauterine pregnancies, and spontaneous miscarriages.
Abortion, Spontaneous
Vascular Endothelial Growth Factor (VEGF) and the VEGF Soluble Receptor-1 (sFlt-1) in Chorionic Villus Tissue from Chinese Women with Early Recurrent Spontaneous Abortion.
Abortion, Spontaneous
Vascular endothelial growth factor and recurrent spontaneous abortion: A meta-analysis.
Abortion, Spontaneous
Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss.
Abortion, Spontaneous
[Growth factors are markers of placental insufficiency in third-trimester miscarriage].
Abortion, Threatened
Production of vascular endothelial growth factor and endothelin in the placenta and umbilical cord during normal and complicated pregnancy.
Abortion, Threatened
Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?
Abortion, Threatened
The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion.
Abscess
Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF.
Acidosis
Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine.
Acidosis
Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.
Acidosis
Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.
Acidosis
Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Acidosis
Multifunctional Albumin-MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response.
Acidosis
Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells.
Acquired Immunodeficiency Syndrome
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor.
Acquired Immunodeficiency Syndrome
Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts* *This work was supported by grants-in-aid from the T. J. Martell Foundation for Leukemia, Cancer, and Aids Research; and the Hans E. Schapira, M.D., Foundation for Urologic Research.
Acquired Immunodeficiency Syndrome
Complement levels and circulating immune complexes in a controlled, longitudinal, multicentre study on effects of intravenous immunoglobulin in adults with AIDS-related complex/Walter-Reed 5. The ARC-IVIG Study Group.
Acquired Immunodeficiency Syndrome
Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass.
Acquired Immunodeficiency Syndrome
Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Acquired Immunodeficiency Syndrome
Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
Acquired Immunodeficiency Syndrome
Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.
Acquired Immunodeficiency Syndrome
Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma.
Acro-Osteolysis
Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis.
Acromegaly
Plasma levels of vascular endothelial growth factor in patients with acromegaly.
Acromegaly
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
Acromegaly
The effects of growth hormone status on circulating levels of vascular growth factors.
Acute Coronary Syndrome
Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes.
Acute Coronary Syndrome
Concentration of vascular endothelial growth factor in patients with acute coronary syndrome.
Acute Coronary Syndrome
Gene electro transfer of plasmid encoding vascular endothelial growth factor for enhanced expression and perfusion in the ischemic swine heart.
Acute Coronary Syndrome
Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent.
Acute Coronary Syndrome
Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay.
Acute Coronary Syndrome
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Acute Coronary Syndrome
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Acute Coronary Syndrome
Prognostic value of placental growth factor in patients with acute chest pain.
Acute Coronary Syndrome
Wenyang Huoxue Jiedu formula inhibits thin-cap fibroatheroma plaque formation via the VEGF/VEGFR signaling pathway.
Acute Coronary Syndrome
[Evaluation of selected vascular active factors in patients after myocardial infarction subjected to cardiac rehabilitation].
Acute Kidney Injury
Acute renal failure during the "off" period after sunitinib administration: Possible mechanism of vascular endothelial growth factor cascade hyperactivation.
Acute Kidney Injury
Complement depletion during haemofiltration with polyacrilonitrile membranes.
Acute Kidney Injury
Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats.
Acute Kidney Injury
Effects of histamine and the h2 receptor antagonist ranitidine on ischemia-induced acute renal failure: involvement of IL-6 and vascular endothelial growth factor.
Acute Kidney Injury
Enhanced vascular endothelial growth factor and inflammatory cytokine removal with online hemodiafiltration over high-flux hemodialysis in sepsis-related acute kidney injury patients.
Acute Kidney Injury
Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.
Acute Kidney Injury
Plasma protein extravasation and vascular endothelial growth factor expression with endothelial nitric oxide synthase induction in gentamicin-induced acute renal failure in rats.
Acute Kidney Injury
Protective effect of vascular endothelial growth factor against cardiopulmonary bypass-associated acute kidney injury in beagles.
Acute Kidney Injury
Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltration.
Acute Lung Injury
Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury.
Acute Lung Injury
Effects of Vascular Endothelial Growth Factor in Recovery Phase of Acute Lung Injury in Mice.
Acute Lung Injury
Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.
Acute Lung Injury
Protective role of vascular endothelial growth factor in endotoxin-induced acute lung injury in mice.
Acute Lung Injury
Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.
Acute Lung Injury
Reduced vascular endothelial growth factor correlates with alveolar epithelial damage after experimental ischemia and reperfusion.
Acute Lung Injury
Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury.
Acute Lung Injury
The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.
Acute Lung Injury
Variations in the Vascular Endothelial Growth Factor Pathway Predict Pulmonary Complications.
Acute Lung Injury
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Acute Lung Injury
Vascular endothelial growth factor and related molecules in acute lung injury.
Acute Lung Injury
Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome.
Acute Lung Injury
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury.
Acute Lung Injury
VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema.
Acute Lung Injury
Vegf-d promotes pulmonary oedema in hyperoxic acute lung injury.
Acute Lung Injury
[The protective effect of angiopoietin-1 on early acute lung injury induced by oleic acid in mice]
Adenocarcinoma
17beta-estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells.
Adenocarcinoma
A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina.
Adenocarcinoma
A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor.
Adenocarcinoma
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung.
Adenocarcinoma
A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
Adenocarcinoma
A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Adenocarcinoma
Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor.
Adenocarcinoma
Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Adenocarcinoma
Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Adenocarcinoma
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
Adenocarcinoma
Angiogenesis in normal tissue adjacent to colon cancer.
Adenocarcinoma
Angiogenic factors in normal endometrium and endometrial adenocarcinoma.
Adenocarcinoma
Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
Adenocarcinoma
Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor.
Adenocarcinoma
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Adenocarcinoma
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Adenocarcinoma
AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes.
Adenocarcinoma
Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
Adenocarcinoma
Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy.
Adenocarcinoma
Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma.
Adenocarcinoma
Association of VEGF genotype with mRNA level in colorectal adenocarcinomas.
Adenocarcinoma
Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells.
Adenocarcinoma
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers.
Adenocarcinoma
Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Adenocarcinoma
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Adenocarcinoma
Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells.
Adenocarcinoma
CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
Adenocarcinoma
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Adenocarcinoma
Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
Adenocarcinoma
Cholesteryl oligoarginine delivering vascular endothelial growth factor sirna effectively inhibits tumor growth in colon adenocarcinoma.
Adenocarcinoma
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.
Adenocarcinoma
Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma.
Adenocarcinoma
Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients.
Adenocarcinoma
Coexpression of vascular endothelial growth factor and its receptor KDR on gastric adenocarcinoma MGC803 cell line and stimulation of exogenous VEGF(165) to MGC803 cells.
Adenocarcinoma
Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6.
Adenocarcinoma
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
Adenocarcinoma
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Adenocarcinoma
Current status of novel agents in advanced gastroesophageal adenocarcinoma.
Adenocarcinoma
Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma.
Adenocarcinoma
Cytotoxic and Antimicrobial Evaluations of Novel Apoptotic and Anti-Angiogenic Spiro Cyclic 2-Oxindole Derivatives of 2-Amino-tetrahydroquinolin-5-one.
Adenocarcinoma
Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis.
Adenocarcinoma
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Adenocarcinoma
Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model.
Adenocarcinoma
Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma.
Adenocarcinoma
Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity.
Adenocarcinoma
Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.
Adenocarcinoma
Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib.
Adenocarcinoma
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Adenocarcinoma
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
Adenocarcinoma
Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor.
Adenocarcinoma
Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy.
Adenocarcinoma
Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
Adenocarcinoma
Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer.
Adenocarcinoma
Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Adenocarcinoma
Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma.
Adenocarcinoma
Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma.
Adenocarcinoma
Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Adenocarcinoma
Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma.
Adenocarcinoma
Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Adenocarcinoma
Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Adenocarcinoma
Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
Adenocarcinoma
Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
Adenocarcinoma
Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma.
Adenocarcinoma
Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
Adenocarcinoma
Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
Adenocarcinoma
Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas.
Adenocarcinoma
Expression of vascular endothelial growth factor and epidermal growth factor receptor in pancreatic ductal adenocarcinomas, neuroendocrine tumours and chronic pancreatitis.
Adenocarcinoma
Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration.
Adenocarcinoma
Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.
Adenocarcinoma
Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma.
Adenocarcinoma
Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection.
Adenocarcinoma
Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
Adenocarcinoma
Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma.
Adenocarcinoma
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.
Adenocarcinoma
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Adenocarcinoma
Hepatocyte Growth Factor Mediated Cell Invasion in Pancreatic Cancer Cells Is Dependent on Neuropilin-1.
Adenocarcinoma
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.
Adenocarcinoma
High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
Adenocarcinoma
High serum levels of Transforming Growth Factor-b1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients.
Adenocarcinoma
High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
Adenocarcinoma
Hypoxia in human colorectal adenocarcinoma: Comparison between extrinsic and potential intrinsic hypoxia markers.
Adenocarcinoma
Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer.
Adenocarcinoma
Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.
Adenocarcinoma
Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma.
Adenocarcinoma
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Adenocarcinoma
Incidence and risk of hypertension associated with ramucirumab in cancer patients: A systematic review and meta-analysis.
Adenocarcinoma
Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma.
Adenocarcinoma
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Adenocarcinoma
Increased pro-angiogenic factors, infiltrating neutrophils and CD163(+) macrophages in bronchoalveolar lavage fluid from lung cancer patients.
Adenocarcinoma
Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine.
Adenocarcinoma
Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells.
Adenocarcinoma
International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: MONET1.
Adenocarcinoma
Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats.
Adenocarcinoma
Lack of immunohistochemical detection of VEGF in prostate carcinoma.
Adenocarcinoma
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
Adenocarcinoma
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Adenocarcinoma
Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma.
Adenocarcinoma
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Adenocarcinoma
Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
Adenocarcinoma
Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Adenocarcinoma
Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
Adenocarcinoma
Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Adenocarcinoma
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Adenocarcinoma
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
Adenocarcinoma
Molecular determinants in targeted therapy for esophageal adenocarcinoma.
Adenocarcinoma
Molecular profiling of angiogenesis markers.
Adenocarcinoma
Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
Adenocarcinoma
Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
Adenocarcinoma
Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Adenocarcinoma
Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma.
Adenocarcinoma
Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis.
Adenocarcinoma
Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial ?5 integrin.
Adenocarcinoma
Novel cis-restricted ?-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro.
Adenocarcinoma
Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Adenocarcinoma
Optimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy.
Adenocarcinoma
Phosphatase of Regenerating Liver-3 Induces Angiogenesis by Increasing Extracellular Signal-Regulated Kinase Phosphorylation in Endometrial Adenocarcinoma.
Adenocarcinoma
Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study.
Adenocarcinoma
PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3K/Akt and p38MAPK pathways.
Adenocarcinoma
Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow.
Adenocarcinoma
Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
Adenocarcinoma
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
Adenocarcinoma
Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
Adenocarcinoma
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer.
Adenocarcinoma
Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
Adenocarcinoma
Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Adenocarcinoma
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.
Adenocarcinoma
Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.
Adenocarcinoma
Protein kinase B phosphorylation correlates with vascular endothelial growth factor a and microvessel density in gastric adenocarcinoma.
Adenocarcinoma
Pulmonary adenocarcinoma angiogenesis.
Adenocarcinoma
Ramucirumab: A Review in Advanced Gastric Cancer.
Adenocarcinoma
Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells.
Adenocarcinoma
Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.
Adenocarcinoma
Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue.
Adenocarcinoma
Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.
Adenocarcinoma
Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells.
Adenocarcinoma
Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Adenocarcinoma
Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Adenocarcinoma
Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.
Adenocarcinoma
Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
Adenocarcinoma
SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis.
Adenocarcinoma
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.
Adenocarcinoma
The ?-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor ?B signaling.
Adenocarcinoma
The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Adenocarcinoma
The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
Adenocarcinoma
The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
Adenocarcinoma
The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.
Adenocarcinoma
The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
Adenocarcinoma
The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Adenocarcinoma
Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Adenocarcinoma
Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Adenocarcinoma
Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Adenocarcinoma
Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas.
Adenocarcinoma
Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinoma and chronic pancreatitis.
Adenocarcinoma
Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.
Adenocarcinoma
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Adenocarcinoma
Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma.
Adenocarcinoma
Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma.
Adenocarcinoma
Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma.
Adenocarcinoma
Vascular Endothelial Growth Factor Expression and Neovascularization in Non-Small Cell Lung Carcinoma.
Adenocarcinoma
Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression.
Adenocarcinoma
Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Adenocarcinoma
Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.
Adenocarcinoma
Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
Adenocarcinoma
Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Adenocarcinoma
Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Adenocarcinoma
VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis.
Adenocarcinoma
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.
Adenocarcinoma
VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Adenocarcinoma
VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.
Adenocarcinoma
Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma.
Adenocarcinoma
[Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma]
Adenocarcinoma
[Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma]
Adenocarcinoma
[The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]
Adenocarcinoma
[VEGF-D expression in lung adenocarcinoma with or without acquired resistance to gefitinib and normal lung tissue.]
Adenocarcinoma of Lung
?-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.
Adenocarcinoma of Lung
Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma.
Adenocarcinoma of Lung
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Adenocarcinoma of Lung
Branched ?-(1,4) glucans from Lentinula edodes (L10) in combination with radiation enhance cytotoxic effect on human lung adenocarcinoma through the Toll-like receptor 4 mediated induction of THP-1 differentiation/activation.
Adenocarcinoma of Lung
Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation.
Adenocarcinoma of Lung
Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
Adenocarcinoma of Lung
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Adenocarcinoma of Lung
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Adenocarcinoma of Lung
Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.
Adenocarcinoma of Lung
Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection.
Adenocarcinoma of Lung
HoxB7 PROMOTES GROWTH AND METASTASIS OF LUNG ADENOCARCINOMA CELLS THROUGH REGULATION OF THE TGF-?/SMAD3 SIGNALING.
Adenocarcinoma of Lung
Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism.
Adenocarcinoma of Lung
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma.
Adenocarcinoma of Lung
The Biophysical Property of A549 Cells Transferred by VEGF-D.
Adenocarcinoma of Lung
The effects of cetuximab alone and in combination with endostatin on vascular endothelial growth factor and interleukin-8 expression in human lung adenocarcinoma cells.
Adenocarcinoma of Lung
Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Vascular endothelial growth factor and basic fibroblast growth factor in primary lung carcinomas and the incidence of metastases.
Adenocarcinoma of Lung
Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Adenocarcinoma of Lung
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.
Adenocarcinoma of Lung
VEGF-A and its isoform VEGF(121) mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study.
Adenocarcinoma of Lung
VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN.
Adenocarcinoma of Lung
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma of Lung
[Overexpression of p73 gene inhibits VEGF and bFGF mRNA expression in lung adenocarcinoma cell.]
Adenocarcinoma of Lung
[Relation of vascular endothelial growth factor-D expression to microvessel density, microlymphatic vessel density, and lymph-node metastasis of lung adenocarcinoma]
Adenocarcinoma of Lung
[The effect of TNP-470 on the proliferation and apoptosis of lung adenocarcinoma cells]
Adenocarcinoma of Lung
[VEGF-D expression in lung adenocarcinoma with or without acquired resistance to gefitinib and normal lung tissue.]
Adenocarcinoma, Bronchiolo-Alveolar
Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Adenocarcinoma, Bronchiolo-Alveolar
Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells.
Adenocarcinoma, Bronchiolo-Alveolar
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma, Clear Cell
A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina.
Adenocarcinoma, Clear Cell
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.
Adenocarcinoma, Clear Cell
Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Adenocarcinoma, Follicular
Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Adenocarcinoma, Follicular
S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
Adenocarcinoma, Mucinous
Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Adenoma
An immunohistochemical and ultrastructural study of pancreatic microcystic serous cyst adenoma with special reference to tumor-associated microvasculature and vascular endothelial growth factor in tumor cells.
Adenoma
Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
Adenoma
Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models.
Adenoma
Comparison of lymphatic vessel density and expression of VEGF-C and VEGF-D lymphangiogenic factors in Warthin's tumours and oncocytic adenomas.
Adenoma
Concurrent expression of angiogenic growth factors and neovascularization during tumourigenesis in colorectal carcinoma patients.
Adenoma
Effect of gamma knife radiosurgery on a pituitary gonadotroph adenoma: a histologic, immunohistochemical and electron microscopic study.
Adenoma
Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
Adenoma
Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
Adenoma
Expression of the von Hippel-Lindau Tumor Suppressor Gene in Nonneoplastic and Neoplastic Lesions of the Thyroid.
Adenoma
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Adenoma
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
Adenoma
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Adenoma
Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.
Adenoma
The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Adenoma
Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis.
Adenoma
Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study.
Adenoma
Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
Adenoma
Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
Adenoma
[Association of vascular endothelial growth factor 936C/T polymorphism and the susceptibility to colorectal adenoma.]
Adenoma
[Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma]
Adenoma, Pleomorphic
Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy.
Adenoma, Pleomorphic
The role of the VEGF-C/-D/flt-4 autocrine loop in the pathogenesis of salivary neoplasms.
Adenoma, Pleomorphic
Vascular endothelial growth factor immunoexpression is increased in malignant salivary gland tumors.
Adenoma, Pleomorphic
Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma.
Adenomatous Polyposis Coli
Colon cancer: a civilization disorder.
Adenomatous Polyps
VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.
Adenomyosis
Constitutive and tumor necrosis factor-?-induced activation of nuclear factor-?B in adenomyosis and its inhibition by andrographolide.
Adenomyosis
Effect of GnRHa on apoptosis and release of VEGF in endometrial cell cultures from patients with adenomyosis.
Adenomyosis
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.
Adenomyosis
Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1alpha (HIF-1alpha), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis.
Adenomyosis
Involvement of NADPH oxidase and NF-?B activation in CXCL1 induction by vascular endothelial growth factor in human endometrial epithelial cells of patients with adenomyosis.
Adenomyosis
Proangiogenic features in chronic pelvic pain caused by adenomyosis.
Adenomyosis
Serum levels of vascular endothelial growth factor and cancer antigen 125 are related to the prognosis of adenomyosis patients after interventional therapy.
Adenomyosis
Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
Adenomyosis
[Expression of vascular endothelial growth factor (VEGF) in uterine tissues as one of the mechanisms of algogenezis in adenomyosis, associated with chronic pelvic pain].
Adenomyosis
[Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus]
Adrenal Insufficiency
Reduction of maternal adrenal steroids results in increased VEGF protein without increased eNOS in the ovine placenta.
Adrenocortical Carcinoma
Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.
Agammaglobulinemia
Effects of circulating endothelial progenitor cells, serum vascular endothelial growth factor and hypogammaglobulinemia in Perthes disease.
Airway Obstruction
Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury.
Airway Obstruction
Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.
Airway Obstruction
Remodeling in asthma and chronic obstructive pulmonary disease.
Albuminuria
Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.
Albuminuria
Angiopoietins: vascular growth factors looking for roles in glomeruli.
Albuminuria
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.
Albuminuria
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
Albuminuria
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?
Albuminuria
Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
Albuminuria
Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
Albuminuria
Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex.
Albuminuria
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Albuminuria
Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.
Albuminuria
Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Albuminuria
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
Albuminuria
Mesangial immune complex glomerulonephritis due to complement factor D deficiency.
Albuminuria
Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes.
Albuminuria
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Albuminuria
Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
Albuminuria
Role of Complement Component C1q in the Onset of Preeclampsia in Mice.
Albuminuria
Silencing of hypoxia-inducible factor-1? gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats.
Albuminuria
The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.
Albuminuria
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
Albuminuria
Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus.
Albuminuria
Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus.
Albuminuria
Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta1 and VEGF.
Alopecia
Alopecia in patients treated with molecularly targeted anticancer therapies.
Alopecia
Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss.
Alopecia
Loss of vascular endothelial growth factor in human alopecia hair follicles.
Alopecia
Vascular endothelial growth factor and its receptor may be one molecular mechanism for androgenetic alopecia.
Alopecia Areata
Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Altitude Sickness
Associations between Vascular Endothelial Growth Factor Gene Polymorphisms and Susceptibility to Acute Mountain Sickness.
Altitude Sickness
B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness.
Altitude Sickness
Cerebrovascular dynamics and vascular endothelial growth factor in acute mountain sickness.
Altitude Sickness
Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness.
Altitude Sickness
Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness.
Altitude Sickness
No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
Altitude Sickness
Plasma vascular endothelial growth factor in acute mountain sickness.
Altitude Sickness
Variability in pulmonary function following rapid altitude ascent to the Amundsen-Scott South Pole station.
Altitude Sickness
Vascular endothelial growth factor and acute mountain sickness.
Alveolar Bone Loss
Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Alzheimer Disease
-1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
Alzheimer Disease
Amyloid-?(25-35), an amyloid-?(1-42) surrogate, and proinflammatory cytokines stimulate VEGF-A secretion by cultured, early passage, normoxic adult human cerebral astrocytes.
Alzheimer Disease
Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han.
Alzheimer Disease
Association of serum vascular endothelial growth factor levels and cerebral microbleeds in patients with Alzheimer's disease.
Alzheimer Disease
Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.
Alzheimer Disease
Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease.
Alzheimer Disease
Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
Alzheimer Disease
Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
Alzheimer Disease
Dynamics of a heparin-binding domain of VEGF(165) complexed with its inhibitor triamterene.
Alzheimer Disease
Encapsulated VEGF-Secreting Cells Enhance Proliferation of Neuronal Progenitors in the Hippocampus of A?PP/Ps1 Mice.
Alzheimer Disease
Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease.
Alzheimer Disease
From angiogenesis to neuropathology.
Alzheimer Disease
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.
Alzheimer Disease
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.
Alzheimer Disease
Increased serum concentrations of transforming growth factor-?1 (TGF-?1) in patients with Guillain-Barré syndrome.
Alzheimer Disease
Low serum VEGF levels are associated with Alzheimer's disease.
Alzheimer Disease
No Association of VEGF Polymorphims with Alzheimer's Disease.
Alzheimer Disease
Reduction in Vascular Endothelial Growth Factor Expression in the Superior Temporal, Hippocampal, and Brainstem Regions in Alzheimer's Disease.
Alzheimer Disease
The A? Peptides-Activated Calcium-Sensing Receptor Stimulates the Production and Secretion of Vascular Endothelial Growth Factor-A by Normoxic Adult Human Cortical Astrocytes.
Alzheimer Disease
The Amyloid-?42 Proxy, Amyloid-?25-35, Induces Normal Human Cerebral Astrocytes to Produce Amyloid-?42.
Alzheimer Disease
The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.
Alzheimer Disease
The Role of Mast Cells in Alzheimer's Disease.
Alzheimer Disease
The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline: Exploring Interactions With Biomarkers of Alzheimer Disease.
Alzheimer Disease
Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis.
Alzheimer Disease
Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia.
Alzheimer Disease
Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: A meta-analysis.
Alzheimer Disease
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment.
Alzheimer Disease
VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease.
Alzheimer Disease
[Levels of proinflammatory cytokines and vascular endothelial growth factor in patients with Alzheimer's disease and mild cognitive impairment].
Ameloblastoma
Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
Ameloblastoma
Evaluation and Comparison of Vascular Endothelial Growth Factor Expression between Ameloblastoma and Keratocystic Odontogenic Tumor.
Ameloblastoma
Expression of inducible nitric oxide synthase and vascular endothelial growth factor in ameloblastoma.
Amyloid Neuropathies
Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome.
Amyloidosis
Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients.
Amyloidosis
Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.
Amyloidosis
Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
Amyloidosis
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias.
Amyotrophic Lateral Sclerosis
ALS and oxidative stress: the neurovascular scenario.
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis in pregnancy is associated with a vascular endothelial growth factor promoter genotype.
Amyotrophic Lateral Sclerosis
Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line.
Amyotrophic Lateral Sclerosis
Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Clinical and fundamental aspects of angiogenesis and anti-angiogenesis.
Amyotrophic Lateral Sclerosis
CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.
Amyotrophic Lateral Sclerosis
Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.
Amyotrophic Lateral Sclerosis
Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Extraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons.
Amyotrophic Lateral Sclerosis
Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
Amyotrophic Lateral Sclerosis
Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
Amyotrophic Lateral Sclerosis
Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Impaired Cytoplasmic-Nuclear Transport of Hypoxia-Inducible Factor-1? in Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis
Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region.
Amyotrophic Lateral Sclerosis
Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
Amyotrophic Lateral Sclerosis
Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.
Amyotrophic Lateral Sclerosis
Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS.
Amyotrophic Lateral Sclerosis
Triple-Gene Therapy for Stroke: A Proof-of-Concept
Amyotrophic Lateral Sclerosis
Vascular endothelial growth factor and amyotrophic lateral sclerosis: The Interplay with exercise and non-invasive ventilation.
Amyotrophic Lateral Sclerosis
Vascular Endothelial Growth Factor Attenuates Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line Induced by Cerebrospinal Fluid of Sporadic Amyotrophic Lateral Sclerosis Patients.
Amyotrophic Lateral Sclerosis
Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
Amyotrophic Lateral Sclerosis
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
Amyotrophic Lateral Sclerosis
Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration.
Amyotrophic Lateral Sclerosis
VEGF and ALS.
Amyotrophic Lateral Sclerosis
VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK.
Anal Gland Neoplasms
VEGF and 17-?-estradiol levels after tamoxifen administration in canine hepatoid gland adenomas and hepatoid gland epitheliomas.
Anaplasia
Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.
Anaplasia
Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.
Anaplasia
Tenascin in Meningioma: Expression Is Correlated with Anaplasia, Vascular Endothelial Growth Factor Expression, and Peritumoral Edema But Not with Tumor Border Shape.
Androgen-Insensitivity Syndrome
Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.
Anemia
Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF).
Anemia
Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1.
Anemia
Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients.
Anemia
Endostatin improves cancer-associated systemic syndrome in a lung cancer model.
Anemia
Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients.
Anemia
Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure.
Anemia
Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.
Anemia
Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia.
Anemia
Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
Anemia
Myocardial vascular and metabolic adaptations in chronically anemic fetal sheep.
Anemia
Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.
Anemia
Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells.
Anemia
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis.
Anemia
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.
Anemia
[A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
Anemia
[Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia]
Anemia, Aplastic
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.
Anemia, Aplastic
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.
Anemia, Aplastic
Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children.
Anemia, Aplastic
[Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia]
Anemia, Aplastic
[Expression of vascular endothelial growth factor in patients with aplastic anemia and its significance]
Anemia, Aplastic
[Serum Levels of sVCAM-1, IL-18 and VEGF in Patients with Aplastic Anemia and Their Clinical Significance.]
Anemia, Hemolytic
Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice.
Anemia, Iron-Deficiency
Blessing for the Bleeder: Bevacizumab in Hereditary Hemorrhagic Telangiectasia.
Anemia, Iron-Deficiency
Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.
Anemia, Iron-Deficiency
Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
Anemia, Sickle Cell
Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.
Anemia, Sickle Cell
Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia.
Anemia, Sickle Cell
Clinical relevance of vascular endothelial growth factor levels in sickle cell disease.
Anemia, Sickle Cell
Cytokines and plasma factors in sickle cell disease.
Anemia, Sickle Cell
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.
Anemia, Sickle Cell
Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.
Anemia, Sickle Cell
Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older.
Anemia, Sickle Cell
Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells.
Anemia, Sickle Cell
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Anemia, Sickle Cell
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Anemia, Sickle Cell
The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease.
Aneurysm
Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines.
Aneurysm
Acceleration of aneurysm healing by P(DLLA-co-TMC)-coated coils enabling the controlled release of vascular endothelial growth factor.
Aneurysm
Aneurysm embolization with biologically active coils: an animal study.
Aneurysm
Concentration analysis of hypoxi-inducible factor-1?; and vascular endothelial growth factor in patients with aortic aneurysm at different stages and its clinical significance.
Aneurysm
Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model.
Aneurysm
Embolization of a common carotid aneurysm with rhVEGF coupled to a pH-responsive chitosan in a rat model.
Aneurysm
Endovascular treatment of aneurysms: healing mechanisms in a Swine model are associated with increased expression of matrix metalloproteinases, vascular cell adhesion molecule-1, and vascular endothelial growth factor, and decreased expression of tissue inhibitors of matrix metalloproteinases.
Aneurysm
Erythropoietin Stimulates Endothelial Progenitor Cells to Induce Endothelialization in an Aneurysm Neck After Coil Embolization by Modulating Vascular Endothelial Growth Factor.
Aneurysm
Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms.
Aneurysm
Heparin and Vascular Endothelial Growth Factor Loaded Poly(L-lactide-co-caprolactone) Nanofiber Covered Stent-Graft for Aneurysm Treatment.
Aneurysm
Heterogeneous histomorphology, yet homogeneous vascular smooth muscle cell dedifferentiation, characterize human aneurysm disease.
Aneurysm
Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
Aneurysm
Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice.
Aneurysm
Vascular endothelial growth factor immobilized on platinum microcoils for the treatment of intracranial aneurysms: experimental rat model study.
Aneurysm, Dissecting
Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database.
Aneurysm, Dissecting
The multitasking role of macrophages in Stanford type A acute aortic dissection.
Aneurysm, Ruptured
Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man.
Angina Pectoris
Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris.
Angina Pectoris
Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris.
Angina Pectoris
Serum levels of vascular endothelial growth factor in patients with angina pectoris and acute myocardial infarction.
Angina, Stable
High frequency home-based exercise decreases levels of vascular endothelial growth factor in patients with stable angina pectoris.
Angina, Stable
Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction.
Angina, Stable
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.
Angina, Stable
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.
Angina, Unstable
Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina.
Angina, Unstable
Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes.
Angina, Unstable
Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction.
Angina, Unstable
Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris.
Angina, Unstable
[Concentration of plasma vascular endothelial growth factor and related factors in patients with unstable angina pectoris].
Angiodysplasia
Increased expression of angiogenic factors in human colonic angiodysplasia.
Angiodysplasia
Increased plasma vascular endothelial growth factor levels in patients with angiodysplasia.
Angiodysplasia
Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
Angiodysplasia
The role of VEGF in angiodysplasia: an intervention study with thalidomide.
Angioedema
Elevated serum levels of TARC/CCL17, eotaxin-3/CCL26 and vascular endothelial growth factor in a patient with non-episodic angioedema associated with eosinophilia and granulomatous cutaneous reaction.
Angioedema
Vascular endothelial growth factor is involved in angioedema associated with eosinophilia.
Angiofibroma
Expression of vascular endothelial growth factor in Juvenile Angiofibroma.
Angiofibroma
Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.
Angiofibroma
Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Angiofibroma
Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas.
Angioid Streaks
Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report.
Angiolipoma
Angiolipoma of the buccal mucosa: a possible role of mast cell-derived VEGF in its enhanced vascularity.
Angiomatosis, Bacillary
Differential effects of Bartonella henselae on human and feline macro- and micro-vascular endothelial cells.
Angiomyolipoma
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/-) Mice Is Superior to Everolimus Alone.
Angiomyolipoma
Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
Angiomyolipoma
Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.
Angiomyolipoma
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.
Angiomyolipoma
Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis.
Angiomyolipoma
Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms.
Aniridia
Analysis of protein composition and protein expression in the tear fluid of patients with congenital aniridia.
Anthrax
A "dock and lock" approach to preparation of targeted liposomes.
Anthrax
A "Dock and Lock" Approach to Preparation of Targeted Liposomes.
Anthrax
Anthrax Lethal Toxin Inhibits Growth of and Vascular Endothelial Growth Factor Release from Endothelial Cells Expressing the Human Herpes Virus 8 Viral G Protein Coupled Receptor.
Anthrax
Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism.
Anthrax
Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders.
Anthrax
Self-assembled "dock and lock" system for linking payloads to targeting proteins.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.
Antiphospholipid Syndrome
Role of the Vitamin D in Leprosy.
Antiphospholipid Syndrome
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.
Antiphospholipid Syndrome
Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Aortic Aneurysm
Concentration analysis of hypoxi-inducible factor-1?; and vascular endothelial growth factor in patients with aortic aneurysm at different stages and its clinical significance.
Aortic Aneurysm, Abdominal
Expression and localization of vascular endothelial growth factor in normal abdominal aorta and abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Expression of angiogenesis and angiogenic factors in human aortic vascular disease.
Aortic Aneurysm, Abdominal
Polymorphisms of genes involved in the hypoxia signaling pathway and the development of abdominal aortic aneurysms or large-artery atherosclerosis.
Aortic Aneurysm, Abdominal
Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice.
Aortic Aneurysm, Thoracic
Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation.
Aortic Valve Stenosis
Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition.
Aortic Valve Stenosis
The role of VEGF in the diabetic patients undergoing endovascular therapy of symptomatic aortic valve stenosis.
Arterial Occlusive Diseases
Designer zinc-finger proteins and their applications.
Arterial Occlusive Diseases
Oxidative stress and increase of vascular endothelial growth factor in plasma of patients with peripheral arterial occlusive disease.
Arterial Occlusive Diseases
Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.
Arteriosclerosis
Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis.
Arteriosclerosis
Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.
Arteriosclerosis
The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis.
Arteriosclerosis
Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.
Arteriosclerosis
Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis.
Arteriosclerosis
[Effects of simvastatin on vasa vasorum and aortic endothelial function in rats]
Arteriovenous Fistula
Effects of brachytherapy on intimal hyperplasia in arteriovenous fistulas in a porcine model.
Arteriovenous Fistula
Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.
Arteriovenous Fistula
Investigation of the mechanism of dural arteriovenous fistula formation induced by high intracranial venous pressure in a rabbit model.
Arteriovenous Malformations
Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain.
Arteriovenous Malformations
Blessing for the Bleeder: Bevacizumab in Hereditary Hemorrhagic Telangiectasia.
Arteriovenous Malformations
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia.
Arteriovenous Malformations
Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
Arteriovenous Malformations
Expression of platelet-derived growth factor ligand and receptor in cerebral arteriovenous and cavernous malformations.
Arteriovenous Malformations
Focal neurons: another source of vascular endothelial growth factor in brain arteriovenous malformation tissues?
Arteriovenous Malformations
Increased expression of angiogenic factors in cultured human brain arteriovenous malformation endothelial cells.
Arteriovenous Malformations
Increased expression of vascular endothelial growth factor and its receptor in enlarging brain arteriovenous malformations - a case report.
Arteriovenous Malformations
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Arteriovenous Malformations
Neurological surgery at the National Institutes of Health.
Arteriovenous Malformations
Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue.
Arteriovenous Malformations
Polymorphisms of the vascular endothelial growth factor A gene and susceptibility to sporadic brain arteriovenous malformation in a Chinese population.
Arteriovenous Malformations
Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population.
Arteriovenous Malformations
Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Arteriovenous Malformations
Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
Arteritis
A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
Arteritis
Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.
Arteritis
Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome.
Arteritis
Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
Arteritis
Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia.
Arteritis
Vascular endothelial growth factor gene polymorphisms in giant cell arteritis.
Arteritis
Vascular endothelial growth factor levels and rheumatic diseases of the elderly.
Arthritis
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction.
Arthritis
Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis.
Arthritis
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
Arthritis
Complement factor D in serum. An indicator of glomerular filtration rate in chronic inflammatory arthritis.
Arthritis
Effect of Bone Marrow Mesenchymal Stem Cell Transplant on Synovial Proliferation in Rats With Type II Collagen-Induced Arthritis.
Arthritis
Effects of total saponins from Rhizoma Dioscoreae Nipponicae on expression of vascular endothelial growth factor and angiopoietin-2 and Tie-2 receptors in the synovium of rats with rheumatoid arthritis.
Arthritis
Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis.
Arthritis
Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
Arthritis
Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer.
Arthritis
Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis.
Arthritis
Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Arthritis
Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice.
Arthritis
Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts.
Arthritis
Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models.
Arthritis
Intra-articular injection of platelet-richplasma reduces inflammation in a house swine model of rheumatoid arthritisof the knee joint.
Arthritis
Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.
Arthritis
Local synovial engagement of angiogenic Tie2 is associated with the development of persistent erosive rheumatoid arthritis in early arthritis patients.
Arthritis
Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.
Arthritis
Myelodysplastic Syndrome Precedes the Onset of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome.
Arthritis
Placenta growth factor is not required for exercise-induced angiogenesis.
Arthritis
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor.
Arthritis
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
Arthritis
Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides.
Arthritis
Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis.
Arthritis
Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis.
Arthritis
The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Arthritis
The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis.
Arthritis
The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor.
Arthritis
The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.
Arthritis
Vascular endothelial growth factor and its inhibitors.
Arthritis
Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.
Arthritis
Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor.
Arthritis
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
Arthritis
Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
Arthritis
ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.
Arthritis
[Effects of qubi zhentong recipe on the expressions of IL-1beta, IL-8, and VEGF in the synovlal of rats with collagen-inducing arthritis].
Arthritis
[Relationship of tetramethylpyrazine on expression of vascular endothelial growth factor and development of adjuvant-induced arthritis in rats]
Arthritis, Experimental
An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor.
Arthritis, Experimental
Effect of Bone Marrow Mesenchymal Stem Cell Transplant on Synovial Proliferation in Rats With Type II Collagen-Induced Arthritis.
Arthritis, Experimental
Effects of cold-damp and hot-damp environment on VEGF and IL-1 expression in joint cartilage cells in adjuvant arthritis in rats.
Arthritis, Experimental
Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors.
Arthritis, Experimental
Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.
Arthritis, Experimental
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice.
Arthritis, Experimental
Relationship between PI3K pathway and angiogenesis in CIA rat synovium.
Arthritis, Experimental
Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
Arthritis, Experimental
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.
Arthritis, Experimental
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis.
Arthritis, Experimental
Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
Arthritis, Experimental
[Relations of synovial angiogenesis and PTEN/PI3K/AKT signaling pathway in rats with adjuvant arthritis].
Arthritis, Experimental
[Up-regulated expressions of HIF-1?, VEGF and CD34 promote synovial angiogenesis in rats with adjuvant arthritis].
Arthritis, Infectious
TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease.
Arthritis, Juvenile
Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.
Arthritis, Juvenile
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor.
Arthritis, Juvenile
Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides.
Arthritis, Juvenile
The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis.
Arthritis, Psoriatic
Pathogenesis of psoriatic arthritis.
Arthritis, Psoriatic
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
Arthritis, Psoriatic
Vascular endothelial growth factor in patients with psoriatic arthritis.
Arthritis, Rheumatoid
A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor.
Arthritis, Rheumatoid
A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis.
Arthritis, Rheumatoid
Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo.
Arthritis, Rheumatoid
Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators.
Arthritis, Rheumatoid
Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes.
Arthritis, Rheumatoid
Amelioration of collagen-induced arthritis in rats by nanogold.
Arthritis, Rheumatoid
An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor.
Arthritis, Rheumatoid
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Arthritis, Rheumatoid
Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis.
Arthritis, Rheumatoid
Anti-citrullinated protein antibody-positive rheumatoid arthritis associated with RS3PE syndrome-like symptoms and an elevated serum vascular endothelial growth factor level in a patient with myasthenia gravis.
Arthritis, Rheumatoid
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Arthritis, Rheumatoid
Anti-TNF-alpha antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study.
Arthritis, Rheumatoid
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes.
Arthritis, Rheumatoid
B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-?.
Arthritis, Rheumatoid
Biomarkers in Rheumatoid Arthritis, what is new?
Arthritis, Rheumatoid
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
Arthritis, Rheumatoid
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis.
Arthritis, Rheumatoid
Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
CD147 induces angiogenesis through vascular endothelial growth factor and hypoxiainducible transcription factor 1?-mediated pathway in rheumatoid arthritis.
Arthritis, Rheumatoid
CD147 induces up-regulation of vascular endothelial growth factor in U937-derived foam cells through PI3K/AKT pathway.
Arthritis, Rheumatoid
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
Arthritis, Rheumatoid
Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients.
Arthritis, Rheumatoid
Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Cocoa polyphenols suppress TNF-?-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells.
Arthritis, Rheumatoid
Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis.
Arthritis, Rheumatoid
Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis.
Arthritis, Rheumatoid
Effect of electro-acupuncture on tumor necrosis factor-? and vascular endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
Arthritis, Rheumatoid
Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Effects of total saponins from Rhizoma Dioscoreae Nipponicae on expression of vascular endothelial growth factor and angiopoietin-2 and Tie-2 receptors in the synovium of rats with rheumatoid arthritis.
Arthritis, Rheumatoid
Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity.
Arthritis, Rheumatoid
Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.
Arthritis, Rheumatoid
Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Rheumatoid
Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA).
Arthritis, Rheumatoid
Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis.
Arthritis, Rheumatoid
Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Arthritis, Rheumatoid
IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes.
Arthritis, Rheumatoid
IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes.
Arthritis, Rheumatoid
IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Immunohistochemical analysis of vascular endothelial growth factor expression in severe and destructive rheumatoid arthritis.
Arthritis, Rheumatoid
Increased expression of endocan in arthritic synovial tissues: effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease.
Arthritis, Rheumatoid
Increasing production of matrix metalloproteinases, tumor necrosis factor-?, vascular endothelial growth factor and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts by different adiponectin isoforms in a concentration-dependent manner.
Arthritis, Rheumatoid
Infliximab: a review of its use in the management of rheumatoid arthritis.
Arthritis, Rheumatoid
Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts.
Arthritis, Rheumatoid
Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells.
Arthritis, Rheumatoid
Interaction Between Smoking and Polymorphism in the Promoter Region of the VEGFA Gene Is Associated with Ischemic Heart Disease and Myocardial Infarction in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
Arthritis, Rheumatoid
Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors.
Arthritis, Rheumatoid
Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.
Arthritis, Rheumatoid
Linking systemic angiogenic factors (VEGF, angiogenin, TIMP-2) and Doppler ultrasound to anti-inflammatory treatment in rheumatoid arthritis.
Arthritis, Rheumatoid
Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Arthritis, Rheumatoid
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice.
Arthritis, Rheumatoid
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.
Arthritis, Rheumatoid
Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
Arthritis, Rheumatoid
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.
Arthritis, Rheumatoid
Phosphatidylserine inhibits inflammatory responses in interleukin-1?-stimulated fibroblast-like synoviocytes and alleviates carrageenan-induced arthritis in rat.
Arthritis, Rheumatoid
Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking.
Arthritis, Rheumatoid
Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.
Arthritis, Rheumatoid
Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
Arthritis, Rheumatoid
Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
Arthritis, Rheumatoid
Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.
Arthritis, Rheumatoid
Recent data on the role for angiogenesis in rheumatoid arthritis.
Arthritis, Rheumatoid
Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
Arthritis, Rheumatoid
Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling.
Arthritis, Rheumatoid
Relationship between PI3K pathway and angiogenesis in CIA rat synovium.
Arthritis, Rheumatoid
Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.
Arthritis, Rheumatoid
Serum concentrations of vascular endothelial growth factor in collagen diseases.
Arthritis, Rheumatoid
Serum vascular endothelial growth factor in late rheumatoid arthritis.
Arthritis, Rheumatoid
Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages.
Arthritis, Rheumatoid
Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
Arthritis, Rheumatoid
Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.
Arthritis, Rheumatoid
Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype.
Arthritis, Rheumatoid
Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis.
Arthritis, Rheumatoid
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte.
Arthritis, Rheumatoid
The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Arthritis, Rheumatoid
The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis.
Arthritis, Rheumatoid
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
Arthritis, Rheumatoid
The relation of serum vascular endothelial growth factor level with disease duration and activity in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.
Arthritis, Rheumatoid
Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts.
Arthritis, Rheumatoid
Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factor in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells.
Arthritis, Rheumatoid
Vascular endothelial growth factor levels and rheumatic diseases of the elderly.
Arthritis, Rheumatoid
Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
Arthritis, Rheumatoid
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Arthritis, Rheumatoid
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
Arthritis, Rheumatoid
VEGF Gene Polymorphisms Affect Serum Protein Levels and Alter Disease Activity and Synovial Lesions in Rheumatoid Arthritis.
Arthritis, Rheumatoid
[Characteristics of vascular morphology and vascular endothelial growth factor in patients with osteoarthritis and rheumatoid arthritis].
Arthritis, Rheumatoid
[Effect of 10-hydroxycamptotbecine on the expression of VEGF in rheumatoid arthritis synovial fibroblasts].
Arthritis, Rheumatoid
[Effect of strengthening Pi and activating blood circulation therapy on serum levels of adrenocorticotrophic hormone and vascular endothelial growth factor in rheumatoid arthritis patients]
Arthritis, Rheumatoid
[Effects of dioscornin tablet containing serum on NF-kappaB p65, STAT3, and VEGF mRNA expressions in rats' synovial cell strain RSC-364 induced by IL-17 and TNF-alpha].
Arthritis, Rheumatoid
[Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts]
Arthritis, Rheumatoid
[Polymorphism in the regulatory regions -?2578A and +C936T of the vascular endothelial growth factor (VEGF-A) gene in Russian women with rheumatoid arthritis].
Arthritis, Rheumatoid
[Relations of synovial angiogenesis and PTEN/PI3K/AKT signaling pathway in rats with adjuvant arthritis].
Arthritis, Rheumatoid
[Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis]
Arthritis, Rheumatoid
[Up-regulated expressions of HIF-1?, VEGF and CD34 promote synovial angiogenesis in rats with adjuvant arthritis].
Aspergillosis
Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor.
Asthma
A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack.
Asthma
A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model.
Asthma
A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma.
Asthma
Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma.
Asthma
Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.
Asthma
Alveolar macrophage-derived VEGF contributes to allergic airway inflammation in a mouse asthma model.
Asthma
Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children.
Asthma
Analysis of growth factors in serum and induced sputum from patients with asthma.
Asthma
Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma.
Asthma
Angiogenesis: a potentially critical part of remodelling in chronic airway diseases?
Asthma
Association of vascular endothelial growth factor polymorphisms with asthma in tunisian children.
Asthma
Association of Vascular Endothelial Growth Factor polymorphisms with childhood asthma, lung function, and airways responsiveness.
Asthma
Associations between Th17-related inflammatory cytokines and asthma in adults: A Case-Control Study.
Asthma
Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms.
Asthma
Azithromycin Attenuates Fibroblast Growth Factors Induced Vascular Endothelial Growth Factor Via p38(MAPK) Signaling in Human Airway Smooth Muscle Cells.
Asthma
Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Asthma
Chlamydophila pneumoniae triggers release of CCL20 and vascular endothelial growth factor from human bronchial epithelial cells through enhanced intracellular oxidative stress and MAPK activation.
Asthma
Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy.
Asthma
Clinical significance of plasma and serum vascular endothelial growth factor in asthma.
Asthma
Clinical significance of serum vascular endothelial growth factor in young male asthma patients.
Asthma
Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
Asthma
Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
Asthma
Effects of academic exam stress on nasal leukotriene B4 and vascular endothelial growth factor in asthma and health.
Asthma
Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma.
Asthma
Effects of leukotriene receptor antagonists on vascular endothelial growth factor levels in asthma.
Asthma
Evaluation of circulating vascular endothelial growth factor and its soluble receptors in patients suffering from persistent allergic rhinitis.
Asthma
Evaluation of the PPAR-? Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial.
Asthma
Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils.
Asthma
Expression of semaphorin 3A and neuropilin 1 in asthma.
Asthma
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Asthma
High vascular endothelial growth factor levels in NZW mice do not correlate with collagen deposition in allergic asthma.
Asthma
IL-9 Induces VEGF Secretion from Human Mast Cells and IL-9/IL-9 Receptor Genes Are Overexpressed in Atopic Dermatitis.
Asthma
Impaired TNFalpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAPkinases and histone acetylation--effect of dexamethasone.
Asthma
Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
Asthma
Increased synthesis of vascular endothelial growth factor in allergic airway inflammation in histidine decarboxylase knockout (HDC(-/-)) mice.
Asthma
Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma.
Asthma
Increased vascular permeability precedes cellular inflammation as asthma control deteriorates.
Asthma
Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway.
Asthma
Is VEGF a potential therapeutic target in asthma?
Asthma
L-2-Oxothiazolidine-4-Carboxylic Acid or ?-Lipoic Acid Attenuates Airway Remodeling: Involvement of Nuclear Factor-?B (NF-?B), Nuclear Factor Erythroid 2p45-Related Factor-2 (Nrf2), and Hypoxia-Inducible Factor (HIF).
Asthma
Markers of autoreactivity, coagulation and angiogenesis in patients with nonallergic asthma.
Asthma
Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implication of vascular endothelial growth factor.
Asthma
Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression.
Asthma
Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta.
Asthma
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation.
Asthma
Polymorphisms in the vascular endothelial growth factor (VEGF) gene associated with asthma.
Asthma
Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma.
Asthma
Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic.
Asthma
Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.
Asthma
Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma.
Asthma
Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma.
Asthma
Remodeling in asthma and chronic obstructive pulmonary disease.
Asthma
Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD.
Asthma
Role of the extracellular signal-regulated kinase 1/2 signaling pathway in regulating the secretion of bronchial smooth muscle cells in a rat model of chronic asthma.
Asthma
Role of vascular endothelial growth factor antagonism on airway remodeling in asthma.
Asthma
Roxithromycin inhibits VEGF-induced human airway smooth muscle cell proliferation: Opportunities for the treatment of asthma.
Asthma
Serum vascular endothelial growth factor as a marker of asthma exacerbation.
Asthma
Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation.
Asthma
Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.
Asthma
TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids.
Asthma
The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma.
Asthma
Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease.
Asthma
Thymoquinone inhibits inflammation, neoangiogenesis and vascular remodeling in asthma mice.
Asthma
Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways.
Asthma
Vascular biomarkers in asthma and COPD.
Asthma
Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.
Asthma
Vascular endothelial growth factor in patients with acute asthma.
Asthma
Vascular endothelial growth factor induction by rhinovirus infection.
Asthma
Vascular endothelial growth factor levels in induced sputum and emphysematous changes in smoking asthmatic patients.
Asthma
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.
Asthma
Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma.
Asthma
Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.
Asthma
Vascular remodeling is airway generation-specific in a primate model of chronic asthma.
Asthma
Vascular remodelling and angiogenesis in asthma: morphological aspects and pharmacological modulation.
Asthma
Vascular remodelling in asthma.
Asthma
VEGFA variants are associated with pre-school lung function, but not neonatal lung function.
Asthma
[Effects of bacterial lipopolysaccharide on serum IL-4, serum IL-8 and pulmonary VEGF expression in mice with asthma].
Asthma
[Modulation of Toll-like signal path of allergic asthma by CpG-ODNs from Bordetella pertussis].
Asthma
[Potential mechanisms of airway remodeling initiated by activated thrombin in asthma]
Asthma
[The effect of a vascular endothelial growth factor receptor inhibitor on airway inflammation and airway remodeling in a murine model of asthma]
Asthma
[The research progress of relationship between the obstructive sleep apnea hypopnea syndrome and asthma].
Asthma
[Vascular endothelial growth factor - structure, function and role in airways inflammation and the clinical course of asthma]
Astrocytoma
Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Astrocytoma
Angiogenesis and its role in the behavior of astrocytic brain tumors.
Astrocytoma
Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.
Astrocytoma
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
Astrocytoma
Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Astrocytoma
Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
Astrocytoma
Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Astrocytoma
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Astrocytoma
Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
Astrocytoma
Expression and hypoxic regulation of angiopoietins in human astrocytomas.
Astrocytoma
Expression and regulation of neuropilin-1 in human astrocytomas.
Astrocytoma
Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Astrocytoma
Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas.
Astrocytoma
Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.
Astrocytoma
Expression of growth factors in brain tumors: correlation with tumor grade, recurrence and survival.
Astrocytoma
EXPRESSION OF INTERLEUKIN-8 (IL-8) RECEPTOR CXCR2 AND SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS-3) IN ASTROCYTIC TUMORS.
Astrocytoma
Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors.
Astrocytoma
Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
Astrocytoma
Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome.
Astrocytoma
Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors.
Astrocytoma
Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients.
Astrocytoma
Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.
Astrocytoma
Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma.
Astrocytoma
Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Astrocytoma
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Astrocytoma
Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Astrocytoma
Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
Astrocytoma
Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Astrocytoma
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
Astrocytoma
Minimal change disease onset observed after bevacizumab administration.
Astrocytoma
miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.
Astrocytoma
Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.
Astrocytoma
Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Astrocytoma
Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.
Astrocytoma
Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells.
Astrocytoma
Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG.
Astrocytoma
Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines.
Astrocytoma
PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.
Astrocytoma
Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors.
Astrocytoma
Ras activation in astrocytomas and neurofibromas.
Astrocytoma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Astrocytoma
The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis.
Astrocytoma
The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells.
Astrocytoma
The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
Astrocytoma
Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
Astrocytoma
Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
Astrocytoma
Vascular Endothelial Growth Factor as an Angiogenic Marker in Malignant Astrocytoma and Oligodendroglioma: An Indian Scenario.
Astrocytoma
Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma.
Astrocytoma
Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Astrocytoma
Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy.
Astrocytoma
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Astrocytoma
[A quantitative pathological study on angiogenesis, vascular endothelial growth factor and inducible nitric oxide synthase in astrocytomas]
Astrocytoma
[Expression of vascular endothelial growth factor in brain astrocytoma and its clinical evaluation]
Astrocytoma
[p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis]
Ataxia Telangiectasia
Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival of gastric cancer.
Atherosclerosis
A study on the association of rs7950273 polymorphism in the PDGFD with ischaemic stroke in the Chinese Han population.
Atherosclerosis
Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP.
Atherosclerosis
Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.
Atherosclerosis
Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells.
Atherosclerosis
Anti-inflammatory effect of glycosaminoglycan derived from Gryllus bimaculatus (a type of cricket, insect) on adjuvant-treated chronic arthritis rat model.
Atherosclerosis
Anti-inflammatory Effect of Isaria sinclairii Glycosaminoglycan in an Adjuvant-treated Arthritis Rat Model.
Atherosclerosis
Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor.
Atherosclerosis
Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
Atherosclerosis
Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells.
Atherosclerosis
Betaxolol stimulates eNOS production associated with LOX-1 and VEGF in Dahl salt-sensitive rats.
Atherosclerosis
Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose.
Atherosclerosis
Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.
Atherosclerosis
Complement components as uremic toxins and their potential role as mediators of microinflammation.
Atherosclerosis
Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis.
Atherosclerosis
Cytokine-inducible growth factor gene expression in human umbilical endothelial cells.
Atherosclerosis
Diabetes mellitus-associated atherosclerosis : mechanisms involved and potential for pharmacological invention.
Atherosclerosis
Effect of obstructive sleep apnea on carotid artery intima media thickness related to inflammation.
Atherosclerosis
Effects of Lys-Glu-Trp peptide on cell-cell interactions and vascular endothelium proliferation under normal conditions and during atherosclerosis.
Atherosclerosis
Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression.
Atherosclerosis
Heritability for plasma VEGF concentration in the Stanislas family study.
Atherosclerosis
High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors.
Atherosclerosis
HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis.
Atherosclerosis
Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages.
Atherosclerosis
Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels.
Atherosclerosis
Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome.
Atherosclerosis
Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells.
Atherosclerosis
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis.
Atherosclerosis
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Atherosclerosis
Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells.
Atherosclerosis
Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells.
Atherosclerosis
Lipoprotein-associated phosphatidylethanol increases the plasma concentration of vascular endothelial growth factor.
Atherosclerosis
Nicotine potentiates vascular endothelial growth factor expression in balloon-injured rabbit aortas.
Atherosclerosis
Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement.
Atherosclerosis
Oxidised LDL decreases VEGFR-1 expression in human monocyte-derived macrophages.
Atherosclerosis
PDGF-C and PDGF-D signaling in vascular diseases and animal models.
Atherosclerosis
Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3.
Atherosclerosis
Phosphatidylethanol in high density lipoproteins increases the vascular endothelial growth factor in smooth muscle cells.
Atherosclerosis
Phosphatidylethanol mediates its effects on the vascular endothelial growth factor via HDL receptor in endothelial cells.
Atherosclerosis
Placenta growth factor is not required for exercise-induced angiogenesis.
Atherosclerosis
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
Atherosclerosis
Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness.
Atherosclerosis
Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
Atherosclerosis
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
Atherosclerosis
Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages.
Atherosclerosis
Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
Atherosclerosis
Radiofrequency-enhanced vascular gene transduction and expression for intravascular MR imaging-guided therapy: feasibility study in pigs.
Atherosclerosis
Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery disease.
Atherosclerosis
Reduction of atherosclerosis in cholesterol-fed rabbits and decrease of expressions of intracellular adhesion molecule-1 and vascular endothelial growth factor in foam cells by a water-soluble fraction of Polygonum multiflorum.
Atherosclerosis
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
Atherosclerosis
Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor.
Atherosclerosis
Salusins and adropin: New peptides potentially involved in lipid metabolism and atherosclerosis.
Atherosclerosis
Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia.
Atherosclerosis
Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment.
Atherosclerosis
Serum VEGF--as a prognostic factor of atherosclerosis.
Atherosclerosis
Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.
Atherosclerosis
Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor.
Atherosclerosis
Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation.
Atherosclerosis
Systemic lupus erythematosus and atherosclerosis: Review of the literature.
Atherosclerosis
The effects of growth hormone status on circulating levels of vascular growth factors.
Atherosclerosis
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models.
Atherosclerosis
The impact of vascular endothelial growth factor +405 C/G polymorphism on long-term outcome and severity of coronary artery disease.
Atherosclerosis
The NF-?B pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs.
Atherosclerosis
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).
Atherosclerosis
Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction.
Atherosclerosis
Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis.
Atherosclerosis
Vascular endothelial growth factor and its inhibitors.
Atherosclerosis
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
Atherosclerosis
Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells.
Atherosclerosis
Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells.
Atherosclerosis
Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients.
Atherosclerosis
Vascular endothelial growth factor promotes cell-cycle transition from G0 to G1 phase in subcultured endothelial cells of diabetic rat thoracic aorta.
Atherosclerosis
Vascular endothelial growth factor-D expression in human atherosclerotic lesions.
Atherosclerosis
Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in vitro.
Atherosclerosis
Vascular endothelial growth factor: angiogenesis, atherogenesis or both?
Atherosclerosis
VEGF and therapeutic opportunities in cardiovascular diseases.
Atherosclerosis
VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor.
Atherosclerosis
VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Atherosclerosis
VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
Atherosclerosis
Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice.
Atherosclerosis
Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL.
Atherosclerosis
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Atherosclerosis
[What is new in the treatment of diabetes?--The importance of nephro- and cardioprotective management]
Atrial Fibrillation
Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation.
Atrial Fibrillation
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
Atrial Fibrillation
Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy.
Atypical Hemolytic Uremic Syndrome
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.
Atypical Hemolytic Uremic Syndrome
Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Autoimmune Diseases
Chronic and non-healing wounds: The story of vascular endothelial growth factor.
Autoimmune Diseases
Investigation on association between five common polymorphisms in vascular endothelial growth factor and prototypes of autoimmune diseases.
Autoimmune Diseases
Luteolin inhibits human keratinocyte activation and decreases NF-?B induction that is increased in psoriatic skin.
Autoimmune Diseases
Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases.
Autoimmune Diseases
Vascular endothelial growth factor (VEGF) in autoimmune diseases.
Azoospermia
Caspase-3 and VEGF immunopositivity in seminiferous tubule germ cells in cases of obstructive and non-obstructive azoospermia in smokers versus non-smokers.
Bacteremia
Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome.
Bacterial Infections
Bacterial induction of pleural mesothelial monolayer barrier dysfunction.
Bacterial Infections
Functional deficiency of complement factor D in a monozygous twin.
Bacterial Infections
Infection of human brain vascular pericytes (HBVPs) by Bartonella henselae.
Bacterial Infections
Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections.
Bacterial Infections
Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome.
Barrett Esophagus
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Bartonella Infections
Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor.
Behcet Syndrome
Association of vascular endothelial growth factor gene polymorphisms with behcet disease in a Korean population.
Behcet Syndrome
EFFECT OF INTRAVITREAL METHOTREXATE AND AQUEOUS HUMOR CYTOKINE LEVELS IN REFRACTORY RETINAL VASCULITIS IN BEHCET DISEASE.
Behcet Syndrome
The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behçet disease.
beta-Thalassemia
Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia.
beta-Thalassemia
Vascular endothelial growth factor in children with thalassemia major.
Biliary Atresia
Genetic Variation in the Vascular Endothelial Growth Factor Gene is Associated With Biliary Atresia.
Biliary Tract Neoplasms
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer.
Biliary Tract Neoplasms
Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma.
Biliary Tract Neoplasms
Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.
Bisphosphonate-Associated Osteonecrosis of the Jaw
Genetic association between VEGF polymorphisms and BRONJ in the Korean population.
Blast Crisis
Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
Blindness
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.
Blindness
Adenosine receptors and caffeine in retinopathy of prematurity.
Blindness
An endothelin type a receptor antagonist reverses upregulated VEGF and icam-1 levels in streptozotocin-induced diabetic rat retina.
Blindness
Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Blindness
Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity.
Blindness
Clinical application of therapies targeting VEGF.
Blindness
Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Blindness
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.
Blindness
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.
Blindness
Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells.
Blindness
Regulation of tight junctions and loss of barrier function in pathophysiology.
Blindness
Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.
Blindness
RETHINKING STOP-ROP: IS IT WORTHWHILE TRYING TO MODULATE EXCESSIVE VEGF LEVELS IN PRETHRESHOLD ROP EYES BY SYSTEMIC INTERVENTION?: A Review of the Role of Oxygen, Light Adaptation State, and Anemia in Prethreshold ROP.
Blindness
Retinal hypoxia induces vascular endothelial growth factor through induction of estrogen-related receptor ?.
Blindness
Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells.
Blindness
Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor.
Blindness
TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration.
Blindness
The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.
Blindness
VEGF-Production by CCR2-Dependent Macrophages Contributes to Laser-Induced Choroidal Neovascularization.
Blindness
Vitreous TIMP-1 levels associate with neovascularization and TGF-?2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.
Blindness
[New drug treatment for age-related macular degeneration]
Blister
Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.
Blister
Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.
Blister
Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level.
Blister
The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report.
Blister
UV radiation induces the release of angiopoietin-2 from dermal microvascular endothelial cells.
Bone Diseases
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Bone Diseases
Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
Bone Diseases
Expression of human VEGF(121) cDNA in mouse bone marrow stromal cells.
Bone Diseases
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
Bone Resorption
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Bone Resorption
Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
Bone Resorption
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Bone Resorption
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.
Bone Resorption
Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts.
Bone Resorption
Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone.
Bone Resorption
Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.
Bowen's Disease
Expression of hypoxia-inducible factor-1?, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
Brain Contusion
Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion.
Brain Contusion
Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion.
Brain Diseases
Could increased vascular endothelial growth factor induced by interleukin 17 be the cause of posterior reversible encephalopathy syndrome in systemic lupus erythematosus?
Brain Diseases
Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability.
Brain Diseases
Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy.
Brain Diseases
Protective Effects of Tetramethylpyrazine on Cerebrovascular Regulations in Rats with Chronic Alcoholic Encephalopathy.
Brain Diseases
Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression.
Brain Diseases
Role of interleukin-6 and vascular endothelial growth factor in Henoch-Schönlein purpura with posterior reversible encephalopathy syndrome.
Brain Diseases
Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy.
Brain Diseases
Vascular endothelial growth factor mediates vasogenic edema in acute lead encephalopathy.
Brain Edema
13-Methyltetradecanoic acid mitigates cerebral ischemia/reperfusion injury.
Brain Edema
A pre-injury high ethanol intake in rats promotes brain edema following traumatic brain injury.
Brain Edema
Alterations in the expression of vascular endothelial growth factor in the rat brain following gamma knife surgery.
Brain Edema
Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas.
Brain Edema
Anti-vasopermeability effects of PEDF in retinal-renal disorders.
Brain Edema
Antiangiogenic therapy for glioblastoma.
Brain Edema
Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis.
Brain Edema
Apatinib in refractory radiation-induced brain edema: A case report.
Brain Edema
AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.
Brain Edema
Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.
Brain Edema
Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion.
Brain Edema
Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Brain Edema
Bevacizumab for the treatment of post-stereotactic radiosurgery adverse radiation effect.
Brain Edema
Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression.
Brain Edema
Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.
Brain Edema
Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas.
Brain Edema
Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
Brain Edema
Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
Brain Edema
Endothelin systems in the brain: involvement in pathophysiological responses of damaged nerve tissues.
Brain Edema
Evaluating the molecular basis for acute mountain sickness: hypoxia response gene expression patterns in warfighters and murine populations.
Brain Edema
Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema.
Brain Edema
Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.
Brain Edema
Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.
Brain Edema
Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness.
Brain Edema
Hypoxia-inducible factor and vascular endothelial growth factor are targets of dietary soy during acute stroke in female rats.
Brain Edema
Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema.
Brain Edema
Lesion Size Is Exacerbated in Hypoxic Rats Whereas Hypoxia-Inducible Factor-1 Alpha and Vascular Endothelial Growth Factor Increase in Injured Normoxic Rats: A Prospective Cohort Study of Secondary Hypoxia in Focal Traumatic Brain Injury.
Brain Edema
Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Brain Edema
No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
Brain Edema
Pathophysiology of Meningioma Growth in Pregnancy.
Brain Edema
Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply.
Brain Edema
Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway.
Brain Edema
Protection of Vascular Endothelial Growth Factor to Brain Edema Following Intracerebral Hemorrhage and Its Involved Mechanisms: Effect of Aquaporin-4.
Brain Edema
Protective effect of albumin on VEGF and brain edema in acute ischemia in rats.
Brain Edema
Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains.
Brain Edema
Surgical brain injury and edema prevention.
Brain Edema
Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Brain Edema
The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas.
Brain Edema
Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema.
Brain Edema
Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
Brain Edema
Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction.
Brain Edema
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain.
Brain Edema
Vascular Endothelial Growth Factor in Brain Edema Formation After Subarachnoid Hemorrhage.
Brain Edema
Vascular endothelial growth factor in tuberculous meningitis.
Brain Edema
Vascular endothelial growth factor is associated with blood brain barrier dysfunction in eosinophilic meningitis caused by Angiostrongylus cantonensis infection.
Brain Edema
Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury.
Brain Edema
[Correlation between vascular endothelial growth factor and peritumoural edema in meningiomas]
Brain Edema
[Efficiency of integrin ?v?3 inhibitor Cilengitide in acute cerebral ischemia in rats].
Brain Edema
[Small interfering RNA (siRNA) targeting vascular endothelial growth factor inhibits vascular leakage in brain of rats exposed to high altitude]
Brain Edema
[Vascular endothelial factor of meningomas and peritumoural vasogenic brain edema]
Brain Infarction
Association between kinase insert domain-containing receptor gene polymorphisms and silent brain infarction: a Korean study.
Brain Infarction
Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability.
Brain Infarction
Vascular protection and restorative therapy in ischemic stroke.
Brain Injuries
Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice.
Brain Injuries
Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice.
Brain Injuries
Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.
Brain Injuries
Carbon monoxide potentiation of L-type Ca2+ channel activity increases HIF-1?-independent VEGF expression via an AMPK?/SIRT1-mediated PGC-1?/ERR? axis.
Brain Injuries
Correlation between magnetic resonance perfusion weighted imaging of radiation brain injury and pathology.
Brain Injuries
Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury.
Brain Injuries
Dynamic Changes of Vascular Endothelial Growth Factor and Angiopoietin-1 in Association With Circulating Endothelial Progenitor Cells After Severe Traumatic Brain Injury.
Brain Injuries
Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke.
Brain Injuries
Neurogenic effect of VEGF is related to increase of astrocytes transdifferentiation into new mature neurons in rat brains after stroke.
Brain Injuries
Neuroprotective Effects of Vascular Endothelial Growth Factor Following Hypoxic Ischemic Brain Injury in Neonatal Rats.
Brain Injuries
Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: Dose response and time window.
Brain Injuries
Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats.
Brain Injuries
Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells.
Brain Injuries
Protection of granulocyte-colony stimulating factor to hemorrhagic brain injuries and its involved mechanisms: effects of vascular endothelial growth factor and aquaporin-4.
Brain Injuries
Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.
Brain Injuries
Role of PDGF-D and PDGFR-? in neuroinflammation in experimental ICH mice model.
Brain Injuries
Signaling pathways for early brain injury after subarachnoid hemorrhage.
Brain Injuries
Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injury.
Brain Injuries
Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain.
Brain Injuries
Vascular endothelial growth factor is neuroprotective against ischemic brain injury by inhibiting scavenger receptor A expression on microglia.
Brain Injuries
Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.
Brain Injuries
Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury.
Brain Injuries
VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway.
Brain Injuries
VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure.
Brain Injuries
[Expression changes of Ang-1, Ang-2, Tie-2 and VEGF in co-culturing of endothelial cells and astrocytes after irradiation by X-ray and their significances].
Brain Injuries
[The evaluation neuropsychological development in preterm infants with hypoxic brain injury].
Brain Injuries, Traumatic
Differential expression of capillary VEGF isoforms following traumatic brain injury.
Brain Injuries, Traumatic
Dynamic Changes of Vascular Endothelial Growth Factor and Angiopoietin-1 in Association With Circulating Endothelial Progenitor Cells After Severe Traumatic Brain Injury.
Brain Injuries, Traumatic
Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury.
Brain Injuries, Traumatic
Erythropoietin Mediates Neurobehavioral Recovery and Neurovascular Remodeling Following Traumatic Brain Injury in Rats by Increasing Expression of Vascular Endothelial Growth Factor.
Brain Injuries, Traumatic
Hippocampal Neurogenesis after Traumatic Brain Injury Is Mediated by Vascular Endothelial Growth Factor Receptor-2 and the Raf/MEK/ERK Cascade.
Brain Injuries, Traumatic
Histopathological changes in the choroid plexus after traumatic brain injury in the rats: a histologic and immunohistochemical study.
Brain Injuries, Traumatic
Increased Expression of Vascular Endothelial Growth Factor Attenuates Contusion Necrosis without Influencing Contusion Edema after Traumatic Brain Injury in Rats.
Brain Injuries, Traumatic
Lesion Size Is Exacerbated in Hypoxic Rats Whereas Hypoxia-Inducible Factor-1 Alpha and Vascular Endothelial Growth Factor Increase in Injured Normoxic Rats: A Prospective Cohort Study of Secondary Hypoxia in Focal Traumatic Brain Injury.
Brain Injuries, Traumatic
Neuroprotective Profile of Novel Src Kinase Inhibitors in Rodent Models of Cerebral Ischemia.
Brain Injuries, Traumatic
Pathomorphology of inflammatory response following traumatic brain injury, serum values of interleukins, and gene polymorphisms.
Brain Injuries, Traumatic
Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans.
Brain Injuries, Traumatic
Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma.
Brain Injuries, Traumatic
Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis.
Brain Injuries, Traumatic
The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury.
Brain Injuries, Traumatic
Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury.
Brain Injuries, Traumatic
Vascular endothelial growth factor increases neurogenesis after traumatic brain injury.
Brain Injuries, Traumatic
Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children.
Brain Injuries, Traumatic
Vascular endothelial growth factor is involved in mediating increased de novo hippocampal neurogenesis in response to traumatic brain injury.
Brain Injuries, Traumatic
[Nrp-1 expression in healing process of traumatic brain injury combined with tibial fracture].
Brain Injury, Chronic
Huanglian-Jie-Du-Tang Extract Protects against Chronic Brain Injury after Focal Cerebral Ischemia via Hypoxia-Inducible-Factor-1?-Regulated Vascular Endothelial Growth Factor Signaling in Mice.
Brain Ischemia
Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia.
Brain Ischemia
Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice.
Brain Ischemia
Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial